+Open data
-Basic information
Entry | Database: EMDB / ID: EMD-11980 | |||||||||
---|---|---|---|---|---|---|---|---|---|---|
Title | SARS-CoV-spike RBD bound to two neutralising nanobodies. | |||||||||
Map data | Resolve Cryo-EM in the PHENIX suite used on the half-maps from localised reconstruction. | |||||||||
Sample |
| |||||||||
Function / homology | Function and homology information Maturation of spike protein / viral translation / Translation of Structural Proteins / Virion Assembly and Release / host cell surface / host extracellular space / suppression by virus of host tetherin activity / Induction of Cell-Cell Fusion / structural constituent of virion / host cell endoplasmic reticulum-Golgi intermediate compartment membrane ...Maturation of spike protein / viral translation / Translation of Structural Proteins / Virion Assembly and Release / host cell surface / host extracellular space / suppression by virus of host tetherin activity / Induction of Cell-Cell Fusion / structural constituent of virion / host cell endoplasmic reticulum-Golgi intermediate compartment membrane / entry receptor-mediated virion attachment to host cell / receptor-mediated endocytosis of virus by host cell / Attachment and Entry / membrane fusion / positive regulation of viral entry into host cell / receptor-mediated virion attachment to host cell / receptor ligand activity / host cell surface receptor binding / fusion of virus membrane with host plasma membrane / fusion of virus membrane with host endosome membrane / viral envelope / symbiont-mediated suppression of host type I interferon-mediated signaling pathway / virion attachment to host cell / SARS-CoV-2 activates/modulates innate and adaptive immune responses / host cell plasma membrane / virion membrane / membrane / identical protein binding / plasma membrane Similarity search - Function | |||||||||
Biological species | Severe acute respiratory syndrome coronavirus 2 / Vicugna pacos (alpaca) / Lama glama (llama) | |||||||||
Method | single particle reconstruction / cryo EM / Resolution: 4.01 Å | |||||||||
Authors | Hallberg BM / Das H | |||||||||
Citation | Journal: Science / Year: 2021 Title: Structure-guided multivalent nanobodies block SARS-CoV-2 infection and suppress mutational escape. Authors: Paul-Albert Koenig / Hrishikesh Das / Hejun Liu / Beate M Kümmerer / Florian N Gohr / Lea-Marie Jenster / Lisa D J Schiffelers / Yonas M Tesfamariam / Miki Uchima / Jennifer D Wuerth / Karl ...Authors: Paul-Albert Koenig / Hrishikesh Das / Hejun Liu / Beate M Kümmerer / Florian N Gohr / Lea-Marie Jenster / Lisa D J Schiffelers / Yonas M Tesfamariam / Miki Uchima / Jennifer D Wuerth / Karl Gatterdam / Natalia Ruetalo / Maria H Christensen / Caroline I Fandrey / Sabine Normann / Jan M P Tödtmann / Steffen Pritzl / Leo Hanke / Jannik Boos / Meng Yuan / Xueyong Zhu / Jonathan L Schmid-Burgk / Hiroki Kato / Michael Schindler / Ian A Wilson / Matthias Geyer / Kerstin U Ludwig / B Martin Hällberg / Nicholas C Wu / Florian I Schmidt / Abstract: The pandemic caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) continues to spread, with devastating consequences. For passive immunization efforts, nanobodies have size and cost ...The pandemic caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) continues to spread, with devastating consequences. For passive immunization efforts, nanobodies have size and cost advantages over conventional antibodies. In this study, we generated four neutralizing nanobodies that target the receptor binding domain of the SARS-CoV-2 spike protein. We used x-ray crystallography and cryo-electron microscopy to define two distinct binding epitopes. On the basis of these structures, we engineered multivalent nanobodies with more than 100 times the neutralizing activity of monovalent nanobodies. Biparatopic nanobody fusions suppressed the emergence of escape mutants. Several nanobody constructs neutralized through receptor binding competition, whereas other monovalent and biparatopic nanobodies triggered aberrant activation of the spike fusion machinery. These premature conformational changes in the spike protein forestalled productive fusion and rendered the virions noninfectious. | |||||||||
History |
|
-Structure visualization
Movie |
Movie viewer |
---|---|
Structure viewer | EM map: SurfViewMolmilJmol/JSmol |
Supplemental images |
-Downloads & links
-EMDB archive
Map data | emd_11980.map.gz | 1.4 MB | EMDB map data format | |
---|---|---|---|---|
Header (meta data) | emd-11980-v30.xml emd-11980.xml | 19.9 KB 19.9 KB | Display Display | EMDB header |
FSC (resolution estimation) | emd_11980_fsc.xml | 20.9 KB | Display | FSC data file |
Images | emd_11980.png | 75.6 KB | ||
Others | emd_11980_half_map_1.map.gz emd_11980_half_map_2.map.gz | 764.7 MB 764.7 MB | ||
Archive directory | http://ftp.pdbj.org/pub/emdb/structures/EMD-11980 ftp://ftp.pdbj.org/pub/emdb/structures/EMD-11980 | HTTPS FTP |
-Related structure data
Related structure data | 7b17MC 7b14C 7b18C 7kn5C 7kn6C 7kn7C 7ksgC M: atomic model generated by this map C: citing same article (ref.) |
---|---|
Similar structure data |
-Links
EMDB pages | EMDB (EBI/PDBe) / EMDataResource |
---|---|
Related items in Molecule of the Month |
-Map
File | Download / File: emd_11980.map.gz / Format: CCP4 / Size: 1.5 MB / Type: IMAGE STORED AS FLOATING POINT NUMBER (4 BYTES) | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Annotation | Resolve Cryo-EM in the PHENIX suite used on the half-maps from localised reconstruction. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Voxel size | X=Y=Z: 1.02 Å | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Density |
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Symmetry | Space group: 1 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Details | EMDB XML:
CCP4 map header:
|
-Supplemental data
-Half map: Half map 1 from the localised reconstruction.
File | emd_11980_half_map_1.map | ||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Annotation | Half map 1 from the localised reconstruction. | ||||||||||||
Projections & Slices |
| ||||||||||||
Density Histograms |
-Half map: Half map 1 from the localised reconstruction.
File | emd_11980_half_map_2.map | ||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Annotation | Half map 1 from the localised reconstruction. | ||||||||||||
Projections & Slices |
| ||||||||||||
Density Histograms |
-Sample components
-Entire : Structure of SARS-CoV-2 spike RBD in complex with SARS-CoV-2 neut...
Entire | Name: Structure of SARS-CoV-2 spike RBD in complex with SARS-CoV-2 neutralizing biparatopic nanobody VE |
---|---|
Components |
|
-Supramolecule #1: Structure of SARS-CoV-2 spike RBD in complex with SARS-CoV-2 neut...
Supramolecule | Name: Structure of SARS-CoV-2 spike RBD in complex with SARS-CoV-2 neutralizing biparatopic nanobody VE type: complex / ID: 1 / Parent: 0 / Macromolecule list: #1-#2 Details: Density from localised reconstruction from full spike - VE data. |
---|---|
Molecular weight | Theoretical: 300 KDa |
-Supramolecule #2: Spike glycoprotein
Supramolecule | Name: Spike glycoprotein / type: complex / ID: 2 / Parent: 1 / Macromolecule list: #1 |
---|---|
Source (natural) | Organism: Severe acute respiratory syndrome coronavirus 2 |
-Supramolecule #3: biparatopic nanobody VE
Supramolecule | Name: biparatopic nanobody VE / type: complex / ID: 3 / Parent: 1 / Macromolecule list: #2 |
---|---|
Source (natural) | Organism: Vicugna pacos (alpaca) |
-Macromolecule #1: Spike protein S1
Macromolecule | Name: Spike protein S1 / type: protein_or_peptide / ID: 1 / Number of copies: 1 / Enantiomer: LEVO |
---|---|
Source (natural) | Organism: Severe acute respiratory syndrome coronavirus 2 |
Molecular weight | Theoretical: 21.90157 KDa |
Recombinant expression | Organism: Homo sapiens (human) |
Sequence | String: NLCPFGEVFN ATRFASVYAW NRKRISNCVA DYSVLYNSAS FSTFKCYGVS PTKLNDLCFT NVYADSFVIR GDEVRQIAPG QTGKIADYN YKLPDDFTGC VIAWNSNNLD SKVGGNYNYL YRLFRKSNLK PFERDISTEI YQAGSTPCNG VEGFNCYFPL Q SYGFQPTN ...String: NLCPFGEVFN ATRFASVYAW NRKRISNCVA DYSVLYNSAS FSTFKCYGVS PTKLNDLCFT NVYADSFVIR GDEVRQIAPG QTGKIADYN YKLPDDFTGC VIAWNSNNLD SKVGGNYNYL YRLFRKSNLK PFERDISTEI YQAGSTPCNG VEGFNCYFPL Q SYGFQPTN GVGYQPYRVV VLSFELLHAP ATVCGPK |
-Macromolecule #2: SARS-CoV-2 neutralizing biparatopic nanobody VE,nanobody E from L...
Macromolecule | Name: SARS-CoV-2 neutralizing biparatopic nanobody VE,nanobody E from Lama glama,SARS-CoV-2 neutralizing biparatopic nanobody VE,nanobody E from Lama glama type: protein_or_peptide / ID: 2 Details: Nanobody V from Vicugna pacos and nanobody E from Lama glama connected with a 15 residue linker,Nanobody V from Vicugna pacos and nanobody E from Lama glama connected with a 15 residue ...Details: Nanobody V from Vicugna pacos and nanobody E from Lama glama connected with a 15 residue linker,Nanobody V from Vicugna pacos and nanobody E from Lama glama connected with a 15 residue linker, 1-119 nanobody from Alpacka, 120-136: linker, 137-263: nanobody from Llama, 264-283: cloning and purification tag,Nanobody V from Vicugna pacos and nanobody E from Lama glama connected with a 15 residue linker,Nanobody V from Vicugna pacos and nanobody E from Lama glama connected with a 15 residue linker, 1-119 nanobody from Alpacka, 120-136: linker, 137-263: nanobody from Llama, 264-283: cloning and purification tag Number of copies: 1 / Enantiomer: LEVO |
---|---|
Source (natural) | Organism: Lama glama (llama) |
Molecular weight | Theoretical: 30.102807 KDa |
Recombinant expression | Organism: Escherichia coli (E. coli) |
Sequence | String: QVQLVETGGG LVQPGGSLRL SCAASGFTFS SYAMGWARQV PGKGLEWVSY IYSDGSTEYQ DSVKGRFTIS RDNAKSTVYL QMNSLKPED TAVYYCATEG SLGGWGRDFG SWGQGTQVTV SSGGGGSGGG GSGGGGSQVQ LVETGGGFVQ PGGSLRLSCA A SGVTLDYY ...String: QVQLVETGGG LVQPGGSLRL SCAASGFTFS SYAMGWARQV PGKGLEWVSY IYSDGSTEYQ DSVKGRFTIS RDNAKSTVYL QMNSLKPED TAVYYCATEG SLGGWGRDFG SWGQGTQVTV SSGGGGSGGG GSGGGGSQVQ LVETGGGFVQ PGGSLRLSCA A SGVTLDYY AIGWFRQAPG KEREGVSCIG SSDGRTYYSD SVKGRFTISR DNAKNTVYLQ MNSLKPEDTA VYYCALTVGT YY SGNYHYT CSDDMDYWGK GTQVTVSSGG YPYDVPDYAG HHHHHH |
-Macromolecule #3: 2-acetamido-2-deoxy-beta-D-glucopyranose
Macromolecule | Name: 2-acetamido-2-deoxy-beta-D-glucopyranose / type: ligand / ID: 3 / Number of copies: 1 / Formula: NAG |
---|---|
Molecular weight | Theoretical: 221.208 Da |
Chemical component information | ChemComp-NAG: |
-Experimental details
-Structure determination
Method | cryo EM |
---|---|
Processing | single particle reconstruction |
Aggregation state | particle |
-Sample preparation
Buffer | pH: 7.4 |
---|---|
Vitrification | Cryogen name: ETHANE |
-Electron microscopy
Microscope | TFS KRIOS |
---|---|
Electron beam | Acceleration voltage: 300 kV / Electron source: FIELD EMISSION GUN |
Electron optics | Illumination mode: FLOOD BEAM / Imaging mode: BRIGHT FIELDBright-field microscopy |
Sample stage | Specimen holder model: FEI TITAN KRIOS AUTOGRID HOLDER / Cooling holder cryogen: NITROGEN |
Image recording | Film or detector model: GATAN K3 BIOQUANTUM (6k x 4k) / Average exposure time: 1.5 sec. / Average electron dose: 48.6 e/Å2 |
Experimental equipment | Model: Titan Krios / Image courtesy: FEI Company |
-Image processing
-Atomic model buiding 1
Refinement | Space: REAL / Protocol: FLEXIBLE FIT |
---|---|
Output model | PDB-7b17: |